MONASH HEALTH
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1860-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://monashhealth.org
Clinical Trials
87
Active:2
Completed:11
Trial Phases
5 Phases
Phase 1:9
Phase 2:7
Phase 3:8
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (82 trials with phase data)• Click on a phase to view related trials
Not Applicable
49 (59.8%)Phase 1
9 (11.0%)Phase 4
9 (11.0%)Phase 3
8 (9.8%)Phase 2
7 (8.5%)No trials found
News
Lung Fibrosis Drug Pirfenidone Shows Promise as COPD Treatment Alternative to Steroids
Researchers at Hudson Institute of Medical Research discovered that Pirfenidone, a drug used to treat lung fibrosis, effectively reduces both viral replication and airway inflammation in COPD without suppressing immune response.
First-in-Human Trial Launches for Novel Extracellular Vesicle Therapy in Crohn's Fistulas
Hudson Institute researchers advance groundbreaking extracellular vesicle treatment derived from amniotic cells into clinical trials for complex perianal Crohn's disease, offering a potential cost-effective alternative to stem cell therapy.